Pembrolizumab (PEM) in patients with advanced/metastatic bone sarcoma (BS) or soft tissue sarcoma (STS): Named patient use by the Medical University of Vienna
Keyword(s):
2014 ◽
Vol 50
(13)
◽
pp. 2289-2297
◽
Keyword(s):
2017 ◽
Vol 98
(2)
◽
pp. 375-383
◽
2014 ◽
Vol 50
(2)
◽
pp. 388-396
◽